Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus

Lupus

Volumn 7, Issue 8, 1998, Pages 530-534

  Sato, H ^a   Akai, Y ^a   Iwano, M ^a   Kurumatani, N ^a   Kurioka, H ^a   Kubo, A ^a   Yamaguchi, T ^a   Fujimoto, T ^a   Dohi, K ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ACE gene insertion deletion (I D) polymorphism; Anti double stranded DNA antibody; Serum complement; SLE disease activity index (SLEDAI); Systemic lupus erythematosus

Indexed keywords

COMPLEMENT; DIPEPTIDYL CARBOXYPEPTIDASE; DNA ANTIBODY;

ADULT; ARTICLE; DISEASE ACTIVITY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031773383     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920622     Document Type: Article

References (35)

1. Steinberg AD et al. Systemic lupus erythematosus. Ann Intern Med 1991; 115: 548-559
2. Schur PH. Genetics of systemic lupus erythematosus. Lupus 1995; 4: 425-437
3. Reinertsen JL et al. B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med 1978; 299: 515-518.
4. Fronek Z, Timmerman LA, Alper CA, Hahn BH. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542-1543.
5. Tebib JG. Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990; 86: 1961-1967.
6. Rigat B et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
7. Costerousse O, Allegrini J, Lopex M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells; genetic polymorphism of expression in T-lymphocytes. Brochem J 1993; 290: 33-40.
8. Cambien F et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
9. Ohishi M et al. A potent genetic risk factor for restenosis. Nat Genet 1993; 5: 324-325.
10. Raynolds MV et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-1075
11. Harden PN et al. Polymorphisms in angtiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-1542.
12. Yoshida H et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-2169.
13. Yoshida H et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus Kidney Int 1996; 50: 657-664.
14. Weinstock JV, Blum AM, Kassab JT. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in munne schistosomiasis mansoni. Cell Immunol 1987; 107: 180-187.
15. Payan DG. Neuropeptides and inflammation: the role of substance P. Annu Rev Med 1989; 40: 341-352.
16. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982; 25: 1271-1277.
17. Rigat B, Hubert C. Corvol P, Soubrier F PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
18. Bombardier C et al. Derivation of the SLEDAI-A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
19. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Appleton & Lange: Connecticut, 1994, pp 133-136
20. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-1221.
21. Bar-Shavit Z et al. Enhancement of phagocytosis - a newly found activity of Substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980; 94: 1445-1451.
22. Koyama S, Rennard SI, Robbins RA. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1995; 269: L38-L44.
23. Vandekerckhove F et al. Bradykinin induces interleukm-6 and synergizes with interleukin-1. Lymphokine Cytokine Res 1991; 10: 285-289.
24. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FESS Lett 1989; 247: 189-192.
25. Horii Y et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 1993; 43: S71-S75.
26. Malide D, Russo P, Bendayan M. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 1995; 26: 558-564.
27. Finck BK, Chan B, Wofsy D. Interleukin 6 promotes marine lupus in NZB/NZW F1 mice. J Clin Invest 1994; 94: 585-591.
28. Takemura T et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 1994; 424: 459-464.
29. Ryffel B et al. Interleukin-6 exacerbates glomerulonephritis in (NZB × NZW) F1 mice. Am J Pathol 1994; 144: 927-937.
30. Kiberd BA. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol 1993; 4: 58-61.
31. Lebedeva TV, Singh AK. Increased responsiveness of B cells in the murine MRL/lpr model of lupus nephritis to interleukin-1 beta. J Am Soc Nephrol 1995; 5: 1530-1534.
32. Blakemore A et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-1385.
33. Yokoyama H, Kreft B, Kelley VR. Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 1995; 47: 122-130.
34. Hahn BH. Antibodies to DNA. New Engl J Med 1998; 338: 1359-1368.
35. Gladman DD et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994; 21: 1468-1471.